Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	json	split
In the present study the effects of the 48 - hour administration of granulocyte - macrophage colony - stimulating factor ( GM - CSF) ( 100 U / mL) or interleukin - 3 ( IL - 3) ( 100 U / mL) on the proliferative activity of leukemic cells and on the intracellular metabolism and cytotoxic efficacy of a subsequent 12 - hour application of cytosine arabinoside ( ara - C) at doses of 0. 1, 1. 0, 10. 0, and 100. 0 mumol / L were evaluated on bone marrow cells from 17 patients with acute myeloid leukemia.	granulocyte - macrophage colony - stimulating factor,68,120,Gene_or_gene_product	GM - CSF,123,131,Gene_or_gene_product	interleukin - 3,150,165,Gene_or_gene_product	IL - 3,168,174,Gene_or_gene_product	leukemic cells,223,237,Cell	intracellular,249,262,Immaterial_anatomical_entity	cytosine arabinoside,338,358,Chemical	ara - C,361,368,Chemical	bone marrow cells,440,457,Cell	patients,466,474,Organism	acute myeloid leukemia,480,502,Cancer	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 68, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""GM - CSF"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 3"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemic cells"", ""start_span"": 223, ""end_span"": 237, ""type"": ""Cell""}, {""token"": ""intracellular"", ""start_span"": 249, ""end_span"": 262, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cytosine arabinoside"", ""start_span"": 338, ""end_span"": 358, ""type"": ""Chemical""}, {""token"": ""ara - C"", ""start_span"": 361, ""end_span"": 368, ""type"": ""Chemical""}, {""token"": ""bone marrow cells"", ""start_span"": 440, ""end_span"": 457, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 466, ""end_span"": 474, ""type"": ""Organism""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 480, ""end_span"": 502, ""type"": ""Cancer""}]"	train
While in control specimens are ara - C dose - dependent increase in 3H - ara - C uptake was accompanied by a corresponding rise in intracellular ara - C - 5 ' triphosphate ( ara - CTP) levels, ara - CTP concentrations were not increased after GM - CSF or IL - 3 exposure, resulting in a higher ara - C to ara - CTP ratio over controls.	specimens,17,26,Cell	ara - C,31,38,Chemical	3H - ara - C,68,80,Chemical	intracellular,131,144,Immaterial_anatomical_entity	ara - C - 5 ' triphosphate,145,171,Chemical	ara - CTP,174,183,Chemical	ara - CTP,193,202,Chemical	GM - CSF,243,251,Gene_or_gene_product	IL - 3,255,261,Gene_or_gene_product	ara - C,294,301,Chemical	ara - CTP,305,314,Chemical	"[{""token"": ""specimens"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""ara - C"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""3H - ara - C"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ara - C - 5 ' triphosphate"", ""start_span"": 145, ""end_span"": 171, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical""}, {""token"": ""GM - CSF"", ""start_span"": 243, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 255, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}, {""token"": ""ara - C"", ""start_span"": 294, ""end_span"": 301, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 305, ""end_span"": 314, ""type"": ""Chemical""}]"	train
EXPERIMENTAL DESIGN: In this study all of the major members of the matrix metalloproteinase ( MMP - 1, MMP - 2, MMP - 3, MMP - 7, MMP - 9, MMP - 13, MT1 - MMP and MT2 - MMP) / tissue inhibitor of matrix metalloproteinase ( TIMP - 1, TIMP - 2, and TIMP - 3) system have been investigated by immunohistochemistry in a series ( n = 90) of stage III ( Dukes ' C) colorectal cancers.	MMP - 1,94,101,Gene_or_gene_product	MMP - 2,103,110,Gene_or_gene_product	MMP - 3,112,119,Gene_or_gene_product	MMP - 7,121,128,Gene_or_gene_product	MMP - 9,130,137,Gene_or_gene_product	MMP - 13,139,147,Gene_or_gene_product	MT1 - MMP,149,158,Gene_or_gene_product	MT2 - MMP,163,172,Gene_or_gene_product	TIMP - 1,223,231,Gene_or_gene_product	TIMP - 2,233,241,Gene_or_gene_product	TIMP - 3,247,255,Gene_or_gene_product	"[{""token"": ""MMP - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 3"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 7"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 13"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""MT1 - MMP"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""MT2 - MMP"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 1"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 2"", ""start_span"": 233, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 3"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene_or_gene_product""}]"	train
Mutant mice lacking both cyclin - dependent kinase ( CDK) inhibitors p18 ( Ink4c) and p27 ( Kip1) develop a tumor spectrum reminiscent of human multiple endocrine neoplasia ( MEN) syndromes.	mice,7,11,Organism	cyclin - dependent kinase,25,50,Gene_or_gene_product	CDK,53,56,Gene_or_gene_product	p18,69,72,Gene_or_gene_product	Ink4c,75,80,Gene_or_gene_product	p27,86,89,Gene_or_gene_product	Kip1,92,96,Gene_or_gene_product	tumor,108,113,Cancer	human,138,143,Organism	multiple endocrine neoplasia,144,172,Cancer	MEN,175,178,Cancer	"[{""token"": ""mice"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""cyclin - dependent kinase"", ""start_span"": 25, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4c"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""multiple endocrine neoplasia"", ""start_span"": 144, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""MEN"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Cancer""}]"	train
Interleukin - 2 administration was followed by a significant increase in total lymphocytes, CD4 +, CD8 +, CD16 + 56 + ( NK) cells, IL - 6, IL - 12, and CRP ( from P < 0. 04 to P < 0. 000) but no change in IL - 10 and TGFbeta1 during clinical benefit.	Interleukin - 2,0,15,Gene_or_gene_product	lymphocytes,79,90,Cell	CD4,92,95,Gene_or_gene_product	CD8,99,102,Gene_or_gene_product	CD16,106,110,Gene_or_gene_product	56,113,115,Gene_or_gene_product	IL - 6,131,137,Gene_or_gene_product	IL - 12,139,146,Gene_or_gene_product	CRP,152,155,Gene_or_gene_product	IL - 10,205,212,Gene_or_gene_product	TGFbeta1,217,225,Gene_or_gene_product	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocytes"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""CD4"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD16"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""56"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRP"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta1"", ""start_span"": 217, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"	train
Semaphorin 7A ( Sema7A) is a membrane - linked semaphorin that is expressed by human keratinocytes, and we have shown that Sema7A binds to human melanocytes through beta1 - integrins and the Plexin C1 receptor.	Semaphorin 7A,0,13,Gene_or_gene_product	Sema7A,16,22,Gene_or_gene_product	membrane,29,37,Cellular_component	semaphorin,47,57,Gene_or_gene_product	human,79,84,Organism	keratinocytes,85,98,Cell	Sema7A,123,129,Gene_or_gene_product	human,139,144,Organism	melanocytes,145,156,Cell	beta1 - integrins,165,182,Gene_or_gene_product	Plexin C1 receptor,191,209,Gene_or_gene_product	"[{""token"": ""Semaphorin 7A"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sema7A"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cellular_component""}, {""token"": ""semaphorin"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""keratinocytes"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""Sema7A"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""melanocytes"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""beta1 - integrins"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexin C1 receptor"", ""start_span"": 191, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	train
In cultured stable Grm1 - mouse - melanocytic clones, as well as an metabotropic glutamate receptor 1 ( Grm1) expressing human melanoma cell line, C8161, stimulation of Grm1 by its agonist led to the activation of AKT, while preincubation with Grm1 - antagonist abolished Grm1 - agonist - induced AKT activation.	Grm1,19,23,Gene_or_gene_product	mouse,26,31,Organism	melanocytic clones,34,52,Cell	glutamate receptor 1,81,101,Gene_or_gene_product	Grm1,104,108,Gene_or_gene_product	human,121,126,Organism	Grm1,169,173,Gene_or_gene_product	AKT,214,217,Gene_or_gene_product	Grm1,244,248,Gene_or_gene_product	Grm1,272,276,Gene_or_gene_product	AKT,297,300,Gene_or_gene_product	"[{""token"": ""Grm1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""melanocytic clones"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""glutamate receptor 1"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""Grm1"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 244, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 297, ""end_span"": 300, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: AQP1, 3 - 5, and 10 - 12 were expressed in human breast cancer and / or normal breast tissues, and AQP1 and 3 - 5 exhibited differential expression.	AQP1,9,13,Gene_or_gene_product	3,15,16,Gene_or_gene_product	5,19,20,Gene_or_gene_product	10,26,28,Gene_or_gene_product	12,31,33,Gene_or_gene_product	human,52,57,Organism	breast cancer,58,71,Cancer	breast tissues,88,102,Tissue	AQP1,108,112,Gene_or_gene_product	3,117,118,Gene_or_gene_product	5,121,122,Gene_or_gene_product	"[{""token"": ""AQP1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 15, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 19, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""10"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""12"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""breast tissues"", ""start_span"": 88, ""end_span"": 102, ""type"": ""Tissue""}, {""token"": ""AQP1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 117, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 121, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
By modulating beta - catenin levels in a mouse model of melanoma that is based on melanocyte - specific Pten loss and Braf ( V600E) mutation, we demonstrate that beta - catenin is a central mediator of melanoma metastasis to the lymph nodes and lungs.	beta - catenin,14,28,Gene_or_gene_product	mouse,41,46,Organism	melanoma,56,64,Cancer	melanocyte,82,92,Cell	Pten,104,108,Gene_or_gene_product	Braf,118,122,Gene_or_gene_product	V600E,125,130,Amino_acid	beta - catenin,162,176,Gene_or_gene_product	melanoma,202,210,Cancer	lymph nodes,229,240,Multi	lungs,245,250,Organ	"[{""token"": ""beta - catenin"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""melanocyte"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""Pten"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Braf"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""V600E"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Amino_acid""}, {""token"": ""beta - catenin"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Multi""}, {""token"": ""lungs"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Organ""}]"	train
To evaluate the concept that localized delivery of angiogenic factors via virus - mediated gene transfer may be useful in the treatment of ischemic disorders, the replication - deficient adenovirus ( Ad) vector AdCMV. VEGF165 ( where CMV is cytomegalovirus and VEGF is vascular endothelial growth factor) containing the cDNA for human VEGF165, a secreted endothelial cell - specific angiogenic growth factor, was constructed.	adenovirus,187,197,Organism	Ad,200,202,Organism	VEGF165,218,225,Gene_or_gene_product	CMV,234,237,Organism	cytomegalovirus,241,256,Organism	VEGF,261,265,Gene_or_gene_product	vascular endothelial growth factor,269,303,Gene_or_gene_product	cDNA,320,324,Cellular_component	human,329,334,Organism	VEGF165,335,342,Gene_or_gene_product	endothelial cell,355,371,Cell	"[{""token"": ""adenovirus"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Organism""}, {""token"": ""Ad"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Organism""}, {""token"": ""VEGF165"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}, {""token"": ""CMV"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Organism""}, {""token"": ""cytomegalovirus"", ""start_span"": 241, ""end_span"": 256, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 269, ""end_span"": 303, ""type"": ""Gene_or_gene_product""}, {""token"": ""cDNA"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 329, ""end_span"": 334, ""type"": ""Organism""}, {""token"": ""VEGF165"", ""start_span"": 335, ""end_span"": 342, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 355, ""end_span"": 371, ""type"": ""Cell""}]"	train
9E3 / CEF4 was slightly mitogenic for CEF, causing a doubling of [ 3H] thymidine uptake when added to serum - starved CEF. 9E3 / CEF4 was found associated not only with the cell and in the culture medium of Rous sarcoma virus - transformed CEF but also with the extracellular matrix.	9E3,0,3,Gene_or_gene_product	CEF4,6,10,Gene_or_gene_product	CEF,38,41,Cell	serum,102,107,Organism_substance	CEF,118,121,Cell	9E3,123,126,Gene_or_gene_product	CEF4,129,133,Gene_or_gene_product	cell,173,177,Cell	Rous sarcoma virus,207,225,Organism	CEF,240,243,Cell	extracellular matrix,262,282,Cellular_component	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism_substance""}, {""token"": ""CEF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""9E3"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 207, ""end_span"": 225, ""type"": ""Organism""}, {""token"": ""CEF"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 262, ""end_span"": 282, ""type"": ""Cellular_component""}]"	train
The principal types of tumors were plasmacytomas secreting immunoglobulin and novel lymphomas that expressed markers such as Sca - 1, CD4, Thy - 1, CD34 and CD45 ( B220), consistent with an origin very early in B - lymphoid development.	tumors,23,29,Cancer	plasmacytomas,35,48,Cancer	immunoglobulin,59,73,Gene_or_gene_product	lymphomas,84,93,Cancer	Sca - 1,125,132,Gene_or_gene_product	CD4,134,137,Gene_or_gene_product	Thy - 1,139,146,Gene_or_gene_product	CD34,148,152,Gene_or_gene_product	CD45,157,161,Gene_or_gene_product	B220,164,168,Gene_or_gene_product	B - lymphoid,211,223,Cell	"[{""token"": ""tumors"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""plasmacytomas"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""immunoglobulin"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphomas"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""Sca - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD4"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""Thy - 1"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD45"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""B220"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - lymphoid"", ""start_span"": 211, ""end_span"": 223, ""type"": ""Cell""}]"	train
For the purpose of investigating the relationship between the metastatic potential of the tumor as well as the expression of nm23 - H1 mRNA, and for determing the location of the positive sites in the cells, tumor metastasis suppressor gene nm23 - H1 in human hepatocellular carcinoma ( and the nonneoplastic area surrounding the tumor) was detected by in situ hybridization using digoxiginin - labeled nm23 - H1 antisense complementary RNA probe.	tumor,90,95,Cancer	nm23 - H1,125,134,Gene_or_gene_product	cells,201,206,Cell	tumor,208,213,Cancer	nm23 - H1,241,250,Gene_or_gene_product	human,254,259,Organism	hepatocellular carcinoma,260,284,Cancer	nonneoplastic area,295,313,Multi	tumor,330,335,Cancer	digoxiginin,381,392,Chemical	nm23 - H1,403,412,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 260, ""end_span"": 284, ""type"": ""Cancer""}, {""token"": ""nonneoplastic area"", ""start_span"": 295, ""end_span"": 313, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 330, ""end_span"": 335, ""type"": ""Cancer""}, {""token"": ""digoxiginin"", ""start_span"": 381, ""end_span"": 392, ""type"": ""Chemical""}, {""token"": ""nm23 - H1"", ""start_span"": 403, ""end_span"": 412, ""type"": ""Gene_or_gene_product""}]"	train
In human colon carcinoma Colo205 and HT29 xenografts grown in human endosialin - transgenic mice, endosialin expression was largely confined to NG2 - expressing perivascular cells and not CD31 - positive endothelial cells.	human,3,8,Organism	colon carcinoma Colo205,9,32,Cancer	HT29 xenografts,37,52,Cancer	human,62,67,Organism	endosialin,68,78,Gene_or_gene_product	mice,92,96,Organism	endosialin,98,108,Gene_or_gene_product	NG2,144,147,Gene_or_gene_product	perivascular cells,161,179,Cell	CD31,188,192,Gene_or_gene_product	endothelial cells,204,221,Cell	"[{""token"": ""human"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""colon carcinoma Colo205"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""HT29 xenografts"", ""start_span"": 37, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""NG2"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""perivascular cells"", ""start_span"": 161, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""CD31"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 204, ""end_span"": 221, ""type"": ""Cell""}]"	valid
MATERIALS AND METHODS: Human colon carcinoma ( HT29) and murine squamous carcinoma ( SCCVII) clonal cell lines expressing varying levels of VEGF were established and their response to vandetanib was assessed in tissue culture and as solid tumors.	Human,23,28,Organism	colon carcinoma,29,44,Cancer	HT29,47,51,Cell	murine,57,63,Organism	squamous carcinoma,64,82,Cancer	SCCVII,85,91,Cell	cell lines,100,110,Cell	VEGF,140,144,Gene_or_gene_product	vandetanib,184,194,Chemical	tissue,211,217,Tissue	solid tumors,233,245,Cancer	"[{""token"": ""Human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""colon carcinoma"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""HT29"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""squamous carcinoma"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""SCCVII"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""vandetanib"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Tissue""}, {""token"": ""solid tumors"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Cancer""}]"	valid
CSC - high cultures and tumors expressed increased levels of the proangiogenic factors vascular endothelial growth factor and stromal - derived factor 1, and when signaling by either factor was blocked, all aspects of angiogenesis observed in CSC - high cultures and tumors, including microvessel density, perfusion, EPC mobilization / recruitment, and stimulation of endothelial cell activity, were reduced to levels comparable with those observed in CSC - low cultures / tumors.	CSC - high cultures,0,19,Cell	tumors,24,30,Cancer	vascular endothelial growth factor,87,121,Gene_or_gene_product	stromal - derived factor 1,126,152,Gene_or_gene_product	CSC - high cultures,243,262,Cell	tumors,267,273,Cancer	microvessel,285,296,Tissue	EPC,317,320,Cell	endothelial cell,368,384,Cell	CSC - low cultures,452,470,Cell	tumors,473,479,Cancer	"[{""token"": ""CSC - high cultures"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 87, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 126, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""CSC - high cultures"", ""start_span"": 243, ""end_span"": 262, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 267, ""end_span"": 273, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 285, ""end_span"": 296, ""type"": ""Tissue""}, {""token"": ""EPC"", ""start_span"": 317, ""end_span"": 320, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 368, ""end_span"": 384, ""type"": ""Cell""}, {""token"": ""CSC - low cultures"", ""start_span"": 452, ""end_span"": 470, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 473, ""end_span"": 479, ""type"": ""Cancer""}]"	valid
To delineate the roles that oxygen and fibroblast growth factors ( FGFs) play in the process of angiogenesis from the embryonic aorta, we cultured mouse embryonic aorta explants ( thoracic level to lateral vessels supplying the mesonephros and metanephros) in a three - dimensional type I collagen gel matrix.	oxygen,28,34,Chemical	fibroblast growth factors,39,64,Gene_or_gene_product	FGFs,67,71,Gene_or_gene_product	embryonic aorta,118,133,Multi	mouse,147,152,Organism	embryonic aorta explants,153,177,Multi	thoracic,180,188,Multi	lateral vessels,198,213,Multi	mesonephros,228,239,Organ	metanephros,244,255,Organ	type I collagen,282,297,Gene_or_gene_product	"[{""token"": ""oxygen"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""fibroblast growth factors"", ""start_span"": 39, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFs"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic aorta"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Multi""}, {""token"": ""mouse"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Organism""}, {""token"": ""embryonic aorta explants"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Multi""}, {""token"": ""thoracic"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Multi""}, {""token"": ""lateral vessels"", ""start_span"": 198, ""end_span"": 213, ""type"": ""Multi""}, {""token"": ""mesonephros"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Organ""}, {""token"": ""metanephros"", ""start_span"": 244, ""end_span"": 255, ""type"": ""Organ""}, {""token"": ""type I collagen"", ""start_span"": 282, ""end_span"": 297, ""type"": ""Gene_or_gene_product""}]"	test
"In this study, using the human colon cancer cell line HCT116, we find that established HCT116 / IGF1 - R transfectants exhibit a more aggressive transformed phenotype than the parental cell line, as demonstrated by their higher proliferation rate in response to IGF1, higher degree of anchorage - independent growth, resistance to serum deprivation - induced apoptosis, and higher migratory capability in a monolayer "" wounding assay. "" When injected into nude mice, HCT116 / IGF1 - R transfectants were highly invasive and produced distant metastases, whereas the parental cell did not."	human,25,30,Organism	colon cancer cell line HCT116,31,60,Cell	IGF1 - R,96,104,Gene_or_gene_product	parental cell line,176,194,Cell	IGF1,262,266,Gene_or_gene_product	serum,331,336,Organism_substance	monolayer,407,416,Cell	nude mice,456,465,Organism	IGF1 - R,476,484,Gene_or_gene_product	metastases,541,551,Cancer	parental cell,565,578,Cell	"[{""token"": ""human"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""colon cancer cell line HCT116"", ""start_span"": 31, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""IGF1 - R"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""parental cell line"", ""start_span"": 176, ""end_span"": 194, ""type"": ""Cell""}, {""token"": ""IGF1"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 331, ""end_span"": 336, ""type"": ""Organism_substance""}, {""token"": ""monolayer"", ""start_span"": 407, ""end_span"": 416, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 456, ""end_span"": 465, ""type"": ""Organism""}, {""token"": ""IGF1 - R"", ""start_span"": 476, ""end_span"": 484, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastases"", ""start_span"": 541, ""end_span"": 551, ""type"": ""Cancer""}, {""token"": ""parental cell"", ""start_span"": 565, ""end_span"": 578, ""type"": ""Cell""}]"	test
Taken together, our findings suggest that ICAM - 3 stimulates cancer cell migration / invasion via ICAM - 3 / Akt / CREB / MMP pathway regardless of p53 and PTEN status, and this reflects the possibility that ICAM - 3 could be considered as a candidate for anti - cancer drug development and as a cancer diagnostic marker.	ICAM - 3,42,50,Gene_or_gene_product	cancer cell,62,73,Cell	ICAM - 3,99,107,Gene_or_gene_product	Akt,110,113,Gene_or_gene_product	CREB,116,120,Gene_or_gene_product	MMP,123,126,Gene_or_gene_product	p53,149,152,Gene_or_gene_product	PTEN,157,161,Gene_or_gene_product	ICAM - 3,209,217,Gene_or_gene_product	cancer,264,270,Cancer	cancer,297,303,Cancer	"[{""token"": ""ICAM - 3"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""ICAM - 3"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 3"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 264, ""end_span"": 270, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 297, ""end_span"": 303, ""type"": ""Cancer""}]"	test
The resultant tumors display lumen - like morphology, contain carcinoma - like focal areas with intercellular junctions resembling desmosomes, and coexpress epithelial ( cytokeratin) and mesenchymal ( vimentin) cytoskeletal markers.	tumors,14,20,Cancer	lumen,29,34,Immaterial_anatomical_entity	carcinoma,62,71,Cancer	focal areas,79,90,Cellular_component	intercellular junctions,96,119,Cellular_component	desmosomes,131,141,Cellular_component	epithelial,157,167,Cell	cytokeratin,170,181,Gene_or_gene_product	mesenchymal,187,198,Cell	vimentin,201,209,Gene_or_gene_product	cytoskeletal,211,223,Cellular_component	"[{""token"": ""tumors"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""lumen"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""carcinoma"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""focal areas"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cellular_component""}, {""token"": ""intercellular junctions"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Cellular_component""}, {""token"": ""desmosomes"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""epithelial"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""cytokeratin"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""mesenchymal"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Cell""}, {""token"": ""vimentin"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoskeletal"", ""start_span"": 211, ""end_span"": 223, ""type"": ""Cellular_component""}]"	test
